OCP and Quadrise Relaunch Fuel Trial

Quadrise Takes a Major Step Forward With Moroccan OCP Partnership
British firm Quadrise has made significant progress in its partnership with Moroccan group OCP. On Monday, October 26, 2026, the emulsion fuel specialist announced receiving approval from the original equipment manufacturer for a new setup of its 30-day commercial trial at the Jorf Lasfar industrial complex. The project is now set to undergo an agreement with OCP before operations commence, which could pave the way for a future fuel supply contract.
Technical Green Light to Restart the Trial at OCP
The authorization pertains to a revised configuration of the trial, which has been moved to a different production line and furnace at the Jorf Lasfar phosphate complex, located on Morocco’s Atlantic coast. This adjustment follows OCP’s decision in the first quarter of 2025 to shift the program to a more modern facility, necessitating the agreement and technical support from the relevant manufacturer.
Quadrise stated that its equipment is already on site; however, the British company still needs to finalize the agreement with OCP that will govern the trial before any commissioning occurs.
This approval removes a technical obstacle that was delaying the continuation of the project. The timeline now hinges on the conclusion of the agreement between the two partners and the completion of the preparations necessary to launch the industrial trial.
A Partnership Established Since 2022
The collaboration between Quadrise and OCP began in June 2022 with the signing of a materials transfer and cooperation agreement. This led to an industrial demonstration of the MSAR and bioMSAR fuels developed by the British company in November 2023.
During this trial, the burner installed at the OCP site operated at various load levels, reaching its maximum capacity of 33 megawatts. Quadrise presented this operation as the first demonstration of its bioMSAR fuel in a commercial industrial application.
The partnership took a significant step forward on May 28, 2024, with the signing of a commercial framework agreement. This included a paid 30-day trial on a furnace at Jorf Lasfar, an update to the technical-economic study conducted in 2022, and the identification of suppliers capable of ensuring a sustainable production of fuel for the Moroccan group.
The initial program was based on the installation of a five-ton-per-hour MSAR manufacturing unit, designed to emulsify locally available heavy fuel oil. The goal is to assess the fuel’s behavior over an extended period in real operational conditions at the phosphate complex.
MSAR and bioMSAR: Alternative Fuels to Conventional Oil
The MSAR technology involves an emulsion of petroleum residues, water, and additives. This process aims to reduce the reliance on certain more expensive distillates used to adjust the viscosity of heavy fuel oil.
The bioMSAR variant incorporates bio-based materials to replace a portion of fossil hydrocarbons. These solutions target several sectors, including industrial installations, electricity production, and maritime transport.
Quadrise estimates that MSAR could be about 10% cheaper than conventional fuel oil, while also helping to reduce certain pollutant emissions. However, these estimates pertain only to the markets targeted by the company and do not represent a specific assessment of the savings or environmental benefits that could be realized at OCP installations.
For the Moroccan group, the trial aims to ascertain the technical and economic feasibility of this solution in a demanding industrial environment before making any decisions regarding regular procurement.
Supply Contract Negotiations Still Needed
The successful completion of the 30-day trial is a crucial milestone, but it does not automatically guarantee the conclusion of a commercial contract. The 2024 framework agreement anticipated exploring partnerships among refiners, terminal operators, and fuel traders to establish a suitable supply chain.
OCP had expressed its willingness, in a letter of intent, to ultimately conclude a purchase agreement with a supplier licensed to use Quadrise’s technology. This initial commitment remains distinct from a binding supply contract.
In September 2025, Quadrise indicated that it had already received payment for the commercial trial, although the amount was not disclosed. At that time, the equipment was also present on site, but the launch remained contingent on the approval of the original manufacturer.
After considering using a different facility in March 2026, the company reported in July that negotiations were still ongoing regarding the program. The announcement on October 26 thus marks a step forward in validating the new technical configuration, but it does not necessarily mean the trial has begun.
In the longer term, Quadrise hopes to transform OCP’s potential demand into a primary channel for regular MSAR production in Morocco. The company is also looking at other industrial opportunities in the Kingdom and, eventually, access to the Mediterranean market for marine fuels.
Quadrise Reports a Net Loss of £4.2 Million
The announcement of the project’s advancement coincided with the release of Quadrise’s annual results for the fiscal year ending June 30, 2026. The company recorded a net loss of £4.2 million, roughly 55.11 million dirhams, compared to £3.1 million or 40.68 million dirhams the previous year.
Its cash reserves also decreased, dropping from £5.9 million (approximately 77.41 million dirhams) to £2.1 million (about 27.55 million dirhams) over the same period. A capital increase completed in July 2026 allowed it to raise £1.6 million gross, or about 20.99 million dirhams.
Quadrise believes its resources can sustain it until September 30, 2027, provided that its projects and expenditures align with its forecasts. However, its accounts indicate a significant uncertainty regarding the continuity of operations due to the need for additional funding before achieving sustainably positive cash flows.
The Company Explores Various Financing Options
In parallel with the development of its industrial projects, Quadrise’s board is examining several financial and commercial options. Among the avenues being considered are technology licensing, the formation of joint ventures, the entry of a minority investor, or a consolidation with other firms in the sector.
The company plans to provide updates on the conclusions of this review by mid-February 2027. It also noted that no acquisition offer procedures targeting it are currently underway.
For Quadrise, the next decisive step remains the finalization of the agreement with OCP, followed by the industrial trial and assessment of its results. Beyond the technical validation of MSAR, the challenge will be to convert this partnership into a sustainable commercial outlet while also securing the necessary funding to continue its operations.




